Freeman Kevin Lee
Health Catalyst, Inc. · Chief Commercial Officer
Freeman Kevin Lee is listed in public filings as officer: Chief Commercial Officer. This Freeman Kevin Lee insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Health Catalyst, Inc. (HCAT). Investors use Freeman Kevin Lee's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.0M358.7k shares | Grant / ExerciseDec 1, 2025 | $47.6K16.4k shares | $2.90 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.3M375.1k shares | Grant / ExerciseSep 2, 2025 | $15.4K4.6k shares | $3.36 | -- | |
| $1.4M379.7k shares | Grant / ExerciseJun 2, 2025 | $17.3K4.7k shares | $3.63 | -- | |
| $1.8M384.4k shares | Grant / ExerciseMar 3, 2025 | $49.4K10.8k shares | $4.58 | -- | |
| --377k shares | Grant / ExerciseFeb 20, 2025 | Disclosure amount unavailable140k shares | -- | -- | |
| --395.2k shares | Grant / ExerciseFeb 20, 2025 | Disclosure amount unavailable18.3k shares | -- | -- | |
| $2.1M237k shares | SellDec 2, 2024 | $67.1K7.5k shares | $8.94 | -- | |
| $2.2M244.5k shares | Grant / ExerciseDec 1, 2024 | $102.6K11.4k shares | $8.97 | -- | |
| $1.8M255.9k shares | SellSep 3, 2024 | $54.2K7.5k shares | $7.22 | -- | |
| $1.9M263.4k shares | Grant / ExerciseSep 3, 2024 | $20.1K2.8k shares | $7.27 | -- | |
| $1.7M266.2k shares | SellJun 11, 2024 | $49.0K7.5k shares | $6.53 | -- |